Planned early birth for pregnant women with high blood pressure cuts maternal complications by nearly half and reduces the risk of stillbirth, without increasing the likelihood of caesarean section, according to a new Cochrane review.

Discover the role Cochrane Thailand has played in closing the gap between evidence and outcomes. Designated as a WHO Collaborating Centre for Research Synthesis in Reproductive Health, the group has not only generated Cochrane reviews but has also translated those findings into national policy and clinical guidelines.

Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review.

Cochrane has released a pre-print of the protocol for our innovative study that will test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. Gerald Gartlehner from Cochrane Austria, Principal Investigator for the study, discusses how the study works, and what makes it interesting.

Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.

We seek nominations for one upcoming vacant position on the Cochrane Methods Executive, to start in September 2026. Please note the deadline for nominations is Friday, 29 May 2026.

Image Members of Cochrane Russia at a workshop in Kazan When Cochrane Russia was established in 2015, it began as a coordinating hub fo

A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle- income countries, and may reduce newborn deaths.

The Cochrane Collaboration is delighted to announce that Rupa Sarkar starts today as the new Editor in Chief.

Cochrane is launching a new eight-part series of Cochrane Learning Live webinars designed to help systematic reviewers understand and apply the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) framework in evaluating the certainty of evidence in their systematic reviews.

Cochrane has confirmed the two artificial intelligence (AI) tools selected to take part in our innovative platform study evaluating how artificial intelligence could support and enhance key stages of evidence synthesis.

Cochrane has launched an innovative study to test whether artificial intelligence tools can support or enhance evidence synthesis. We only have scope to evaluate two, and so a selection process was required. Here, we outline that process and demonstrate what Cochrane values when deciding whether to use an AI tool for evidence synthesis.

Over the past 10 years Cochrane Taiwan has built a reputation for mobilizing knowledge and promoting evidence-based medicine both in Taiwan and beyond. Here they share some of the successes and learnings that have stood out over the past decade.

We’re pleased to announce four recent improvements to RevMan that will help users to structure analyses more accurately, avoid common Summary of Findings (SoF) issues, and prepare complete synthesis PICOs.

We are delighted to announce the launch of the new Cochrane Thematic Group in Infectious Diseases.

As International Women’s Day is marked around the world, women in leadership roles across the evidence and health sectors are reflecting on their careers, lessons learned and what it means to ‘give’ as a leader.

A comprehensive new systematic review published in The Journal of Nutrition provides the latest evidence that large-scale food fortification is a highly cost-effective intervention for reducing global malnutrition.

A new Cochrane review has found that sucrose can help with pain relief in newborn babies during common hospital procedures, such as venepuncture. This involves drawing blood with a needle, typically for testing.

A new partnership between Cochrane’s publishing partner Wiley and the medical AI platform OpenEvidence will see Cochrane evidence helping to inform the platform’s users, including more than 40% of US physicians.

Title: Cochrane Support Officer
Specifications: Permanent - Full time (37.5 hours)
Salary:  £30,000 per annum 
Location: Remote - Ideally based in the UK, Germany or Denmark. 
Directorate: Publishing and Technology directorate
Closing date: 18 June 2025

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesizing research findings and our work has been recognized as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into four directorates: Evidence Production and Methods, Publishing and Technology, Development, and Finance and Corporate Services.

The Cochrane Support team is the first point of contact for the international Cochrane community. We provide technical and user support to Cochrane editorial teams and review authors; and handle enquiries from members of the public about Cochrane’s work.

We pride ourselves on our timely and coordinated support service, covering a broad range of areas including Cochrane editorial processing and publication, review-writing software, Cochrane Account login, membership, training, and volunteering opportunities. The team is progressively taking on additional IT services tasks.     

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values: Collaboration: Underpins everting we do, locally and globally. Relevant: The right evidence at the right time in the right format. Integrity: Independent and transparent. Quality: Reviewing and improving what we do, maintaining rigour and trust. 

You can expect: 

• An opportunity to truly impact health globally 
• A flexible work environment
• A comprehensive onboarding experiences
• An environment where people feel welcome, heard, and included, regardless of their differences

Cochrane welcomes applications from a wide range of perspectives, experiences, locations and backgrounds; diversity, equity and inclusion are key to our values.

How to apply:

• For further information on the role and how to apply, please click here.
• The deadline to receive your application is 18 June 2025.  We reserve the right to close this vacancy early if we receive sufficient applications for the role. Therefore, if you are interested, please submit your application as early as possible.
• The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.
• Interviews will be held w/c 23 June, 2025.
• Read our Recruitment Privacy Statement
• Read our Candidate pack for more information on the hiring process and staff benefits.

 

Thursday, June 12, 2025 Category: Jobs